Hepion Pharmaceuticals, Inc. (HEPA)
USD 0.56
(0.61%)
USD 0.56
(0.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -40.88 Million | -34.96 Million | -31.22 Million | -16.16 Million | -7.56 Million | -15.64 Million |
| Net Income | -48.92 Million | -42.2 Million | -32.72 Million | -20.35 Million | -7.03 Million | -9.44 Million |
| Depreciation & Amortization | 67.13 Thousand | 77.46 Thousand | 86.07 Thousand | 34.51 Thousand | 26.73 Thousand | 18.78 Thousand |
| Deferred income taxes | -409.02 Thousand | 1.87 Million | - | 6050.00 | 48.32 Thousand | -536 Thousand |
| Stock-based compensation | 1.34 Million | 2.55 Million | 4.66 Million | 2.37 Million | 66.17 Thousand | 234.51 Thousand |
| Change in working capital | 2.97 Million | 3.15 Million | -5.56 Million | 1.62 Million | -826.23 Thousand | -970.48 Thousand |
| Other non-cash items | 4.06 Million | -414.99 Thousand | 2.31 Million | 140 Thousand | 157.27 Thousand | -4.94 Million |
| Investing Cash Flow | -14.3 Thousand | -14.07 Thousand | -130.4 Thousand | -85.78 Thousand | -51.46 Thousand | 900.00 |
| Investments in PPE | -14.3 Thousand | -16.33 Thousand | -130.4 Thousand | -87.98 Thousand | -51.46 Thousand | - |
| Acquisitions | - | 2266.00 | - | 2194.00 | - | 900.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 2.27 | - | 2.19 | - | 0.90 |
| Financing Cash Flow | 4.49 Million | -5.13 Million | 81.97 Million | 43.05 Million | 18.7 Million | 12.52 Million |
| Debt repayment | - | - | -176.58 Thousand | -176.58 Thousand | -2.36 Million | -668.94 Thousand |
| Dividends payments | -1000.00 | - | - | - | - | - |
| Common Stock Repurchased | - | -21 Million | - | - | - | - |
| Common Stock Issuance | 4.49 Million | 17.86 Million | 82.15 Million | 42.86 Million | 7.68 Million | 1.63 Million |
| Other Financing Activities | 1000.00 | 15.86 Million | 82.15 Thousand | 188.58 Thousand | 13.39 Million | 11.55 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 302.91 Thousand | 2.24 Million | -1.06 Million | 3.03 Million | -317.04 Thousand | -897.69 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -302.91 Thousand | 907.03 Thousand | -4.49 Million | -1.41 Million | -509.18 Thousand | -970.48 Thousand |
| Cash at beginning of period | 51.18 Million | 91.34 Million | 40.72 Million | 13.92 Million | 2.83 Million | 5.95 Million |
| Cash at end of period | 14.78 Million | 51.18 Million | 91.34 Million | 40.72 Million | 13.92 Million | 2.83 Million |
| Capital Expenditure | -14.3 Thousand | -16.33 Thousand | -130.4 Thousand | -87.98 Thousand | -51.46 Thousand | - |
| Effect of forex changes on cash | 5024.00 | -47.13 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -36.4 Million | -40.15 Million | 50.62 Million | 26.8 Million | 11.09 Million | -3.12 Million |
| Free Cash Flow | -40.9 Million | -34.97 Million | -31.35 Million | -16.25 Million | -7.61 Million | -15.64 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.92 Million | -2.85 Million | -48.92 Million | -11.05 Million | -10.52 Million | -14.07 Million |
| Depreciation & Amortization | - | 30.75 Thousand | 67.13 Thousand | 12.26 Thousand | 18.5 Thousand | 18.32 Thousand |
| Deferred income taxes | - | - | -409.02 Thousand | 4.09 Million | - | - |
| Stock-based compensation | 28.62 Thousand | 705.77 Thousand | 1.34 Million | 150.32 Thousand | 318.91 Thousand | -1.05 Million |
| Change in working capital | -2.5 Million | -2.13 Million | 2.97 Million | -1.94 Million | -906.7 Thousand | 2.77 Million |
| Other non-cash items | -3.02 Million | 3.9 Million | 4.06 Million | -260 Thousand | -140 Thousand | -88.43 Thousand |
| Investing Cash Flow | - | - | -14.3 Thousand | -348.00 | 2582.00 | -16.53 Thousand |
| Investments in PPE | - | - | -14.3 Thousand | -348.00 | 2582.00 | -16.53 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | 1.84 Million | 4.49 Million | 4.49 Million | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -1000.00 | -1000.00 | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 1.84 Million | 4.49 Million | 4.49 Million | - | - |
| Other Financing Activities | - | 1.84 Million | 1000.00 | 4494.95 | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.47 Million | -2.49 Million | 302.91 Thousand | -1.12 Million | -1.38 Million | 2.24 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.03 Million | 361.36 Thousand | -302.91 Thousand | -815.28 Thousand | 477.97 Thousand | 523.93 Thousand |
| Cash at beginning of period | 13.1 Million | 14.78 Million | 51.18 Million | 19.28 Million | 30.52 Million | 42.99 Million |
| Cash at end of period | 2.11 Million | 13.1 Million | 14.78 Million | 14.78 Million | 19.28 Million | 30.52 Million |
| Capital Expenditure | - | - | -14.3 Thousand | -348.00 | 2582.00 | -16.53 Thousand |
| Effect of forex changes on cash | -61.75 Thousand | 86.7 Thousand | 5024.00 | 8972.00 | -3993.00 | -18.73 Thousand |
| Net cash flow / Change in cash | -10.99 Million | -1.68 Million | -36.4 Million | -4.49 Million | -11.23 Million | -12.47 Million |
| Free Cash Flow | -10.92 Million | -3.61 Million | -40.9 Million | -9 Million | -11.23 Million | -12.45 Million |
EPL
AAC
NSSC
NLY
8370
CNXC